Merck Life Science Partners with GeNext Genomics to Drive Biotech Growth in India

Mumbai (25, November 2024) - Merck Life Science, a leading global life sciences company, has signed a Memorandum of Understanding (MoU) with emerging biotech company, GeNext Genomics. The collaboration aims to harness the synergy between local experts and global biomanufacturing capabilities to support the growth of India’s thriving biotech ecosystem.

The MoU was formally inked at an event attended by high dignitaries including Aditya Sharma, Head of Process Solutions, India Region, Merck Life Science; Dr. Ashwin Kashikar, Managing Director, GeNext Genomics; Supriya Kashikar, Founder and CEO, GeNext Genomics; and Ravi Kashikar, Chairman and Founder of Ankur Seeds.

By partnering with Merck, GeNext Genomics can now offer robust solutions to support the growth of India’s biotech sector. The partnership is expected to yield significant benefits for businesses operating in the ecosystem, enabling them to access cutting-edge biomanufacturing expertise.

" We are thrilled to collaborate with Merck Life Science, a renowned global player in the life sciences industry," said Dr Ashwin Kashikar, Managing Director of GeNext Genomics. "With this partnership, we aim to bridge the gap between technical capabilities and business needs for the biotech sector in India."

This strategic collaboration is aimed at creating a thriving ecosystem that fosters innovation and growth in India’s rapidly expanding biotechnology market.

(Photos caption, quote from Aditya Sharma are available upon request)